X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2328) 2328
Publication (181) 181
Book Chapter (19) 19
Book Review (19) 19
Newsletter (14) 14
Conference Proceeding (5) 5
Magazine Article (5) 5
Book / eBook (4) 4
Newspaper Article (4) 4
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1014) 1014
methylene-blue (782) 782
methylene blue (666) 666
methylene blue - pharmacology (663) 663
male (610) 610
index medicus (571) 571
humans (540) 540
rats (401) 401
pharmacology & pharmacy (399) 399
in vitro techniques (318) 318
arginine - pharmacology (313) 313
arginine - analogs & derivatives (298) 298
female (298) 298
biochemistry & molecular biology (296) 296
nitric oxide (268) 268
methylene blue - analogs & derivatives (224) 224
analysis (195) 195
dose-response relationship, drug (181) 181
kinetics (166) 166
adsorption (150) 150
relaxing factor (150) 150
muscle, smooth, vascular - drug effects (149) 149
nitric oxide - metabolism (149) 149
muscle relaxation - drug effects (148) 148
nitric-oxide (148) 148
chemistry, multidisciplinary (141) 141
methylene blue - chemistry (140) 140
nitric oxide - physiology (134) 134
enzyme inhibitors - pharmacology (133) 133
physiology (133) 133
biophysics (127) 127
rats, wistar (126) 126
rats, sprague-dawley (123) 123
nanoparticles (122) 122
methylenblau (121) 121
mice (121) 121
endothelium, vascular - physiology (120) 120
dyes (119) 119
light (119) 119
nitroprusside - pharmacology (119) 119
photodynamic therapy (115) 115
l-arginine (114) 114
chemistry, physical (111) 111
vasodilator agents - pharmacology (110) 110
ng-nitroarginine methyl ester (109) 109
relaxation (109) 109
omega-n-methylarginine (108) 108
cells (107) 107
nitroarginine (107) 107
chemistry (106) 106
in-vitro (103) 103
chemistry, analytical (100) 100
dna (100) 100
smooth-muscle (100) 100
vasodilation - drug effects (99) 99
nitric oxide - pharmacology (98) 98
oxidation-reduction (98) 98
cyclic gmp - metabolism (97) 97
muscle contraction - drug effects (96) 96
cyclic gmp - pharmacology (95) 95
endothelium (95) 95
catalysis (93) 93
guanylate cyclase - antagonists & inhibitors (92) 92
cells, cultured (91) 91
inhibition (91) 91
cyclic gmp - analogs & derivatives (90) 90
neurosciences (90) 90
research (89) 89
oxidation (87) 87
cancer (85) 85
nitric oxide - antagonists & inhibitors (85) 85
acetylcholine - pharmacology (83) 83
time factors (83) 83
degradation (82) 82
photosensitizing agents - pharmacology (82) 82
fluorescence (81) 81
rabbits (81) 81
engineering, chemical (79) 79
singlet oxygen (79) 79
cattle (77) 77
dogs (77) 77
cyclic-gmp (76) 76
article (75) 75
chemical properties (75) 75
nitric oxide synthase (75) 75
photochemotherapy (75) 75
physiological aspects (75) 75
adult (74) 74
photocatalysis (73) 73
acetylcholine (72) 72
cyclic gmp - physiology (71) 71
electrochemistry (70) 70
research article (70) 70
surgery (70) 70
electric stimulation (69) 69
methylene blue - metabolism (69) 69
nitric oxide synthase - antagonists & inhibitors (69) 69
activation (68) 68
endothelium, vascular - drug effects (68) 68
muscle, smooth, vascular - physiology (67) 67
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2348) 2348
Japanese (20) 20
German (6) 6
Russian (6) 6
Chinese (4) 4
Czech (2) 2
French (1) 1
Italian (1) 1
Polish (1) 1
Portuguese (1) 1
Slovak (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Materials Chemistry. A, Materials for Energy and Sustainability, ISSN 2050-7488, 01/2018, Volume 6, Issue 3, pp. 884 - 895
Nitrogen-doped carbon materials are becoming a new type of metal-free heterogeneous catalysts in advanced oxidation processes (AOPs) for wastewater treatment... 
Cyanide | Organic matter | Catalysts | Metals | Substitution reactions | Homology | Cyanides | Cobalt | Degradation | Microspheres | Water analysis | Pigments | Oxidation | Catalysis | Pollutants | Biodegradation | EGR-1 protein | Nitrogen | Carbon | Wastewater treatment | Zinc | Methylene blue | Water sampling | Environmental degradation | Porosity | Graphitization
Journal Article
Journal of Materials Chemistry A, ISSN 2050-7488, 2018, Volume 6, Issue 3, pp. 884 - 895
Nitrogen-doped carbon materials are becoming a new type of metal-free heterogeneous catalysts in advanced oxidation processes (AOPs) for wastewater treatment... 
REDUCED GRAPHENE OXIDE | ENHANCED ACTIVATION | MESOPOROUS CARBON | NONRADICAL MECHANISM | ENERGY & FUELS | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHEMISTRY, PHYSICAL | SULFATE RADICALS | REACTIVE RADICALS | FACILE SYNTHESIS | ADVANCED OXIDATION PROCESSES | GRAPHITIC CARBON | HETEROGENEOUS CATALYST
Journal Article
by Ai, SS and Guo, X and Zhao, L and Yang, D and Ding, HM
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, ISSN 0927-7757, 11/2019, Volume 581, p. 123796
Prussian blue analogues (PBAs) have gained extensive attention for peroxymonosulfate (PMS) activation. However, the poor recovery ability of PBAs has limited... 
Prussian blue analogues | METHYLENE-BLUE | RHODAMINE-B | CHEMISTRY, PHYSICAL | Activation | CARBON NITRIDE | AQUEOUS-SOLUTION | Degradation | PHOTOCATALYTIC DEGRADATION | METAL-ORGANIC FRAMEWORKS | SULFATE | Zeolitic imidazolate framework | ENHANCED HETEROGENEOUS CATALYST | BISPHENOL-A | Peroxymonosulfate | FACILE PREPARATION
Journal Article
Bioorganic and Medicinal Chemistry, ISSN 0968-0896, 07/2018, Volume 26, Issue 12, pp. 3359 - 3369
Friedreich's ataxia (FRDA) is an autosomal recessive neurodegenerative disorder resulting from reduced expression of the protein frataxin (FXN). Although its... 
Friedreich's ataxia | Mitochondria | Frataxin | Cytoprotection | Methylene blue | CELLS | OXIDATIVE STRESS | DEFECTS | CHEMISTRY, MEDICINAL | ALZHEIMERS-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, ORGANIC | TAU | MATURATION | NEURODEGENERATIVE DISEASES | DEFICIENCY | IRON ACCUMULATION | TRIPLET-REPEAT EXPANSION | Proteins | Sulfur compounds | Ataxia | Nervous system diseases
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 07/2018, Volume 26, Issue 12, pp. 3359 - 3369
Friedreich’s ataxia (FRDA) is an autosomal recessive neurodegenerative disorder resulting from reduced expression of the protein frataxin (FXN). Although its... 
Friedreich’s ataxia | Mitochondria | Frataxin | Methylene blue | Cytoprotection
Journal Article
New Journal of Chemistry, ISSN 1144-0546, 2018, Volume 42, Issue 24, pp. 20212 - 20218
Prussian blue and its analogues (PBAs) have been widely investigated in fields such as lithium-ion batteries (LIB), supercapacitors, catalysts and water... 
STORAGE | METHYLENE-BLUE | NANOPARTICLES | CARBON | OXIDE | NANOCUBES | NANOARCHITECTURES | MAGNETIC-PROPERTIES | METAL-ORGANIC-FRAMEWORKS | CHEMISTRY, MULTIDISCIPLINARY
Journal Article
Journal of Colloid And Interface Science, ISSN 0021-9797, 02/2016, Volume 464, pp. 191 - 197
Prussian blue analogue Zn [Fe(CN) ] ⋅ H O (Zn-PBA) micro-/nanocrystals with well-defined spherical, cubic and polyhedral morphologies have been successfully... 
Micro-/nanocrystals | Synthesis | Organic dye | Adsorption | Prussian blue analogue
Journal Article
Photochemistry and Photobiology, ISSN 0031-8655, 2002, Volume 75, Issue 4, pp. 392 - 397
Abstract We have synthesized a series of symmetrical phenothiazines in which the methyl groups of methylene blue have been substituted by longer alkyl chains.... 
BLADDER-CARCINOMA CELLS | THERAPY | ASSAY | BIOPHYSICS | PHOTOCHEMOTHERAPY | BIOCHEMISTRY & MOLECULAR BIOLOGY | PHOTOSENSITIZERS | BENZOPHENOTHIAZINE | TUMOR-CELLS | DERIVATIVES | MOLECULAR PROBES | LIVING CELLS | Mice | Animals | Tumor Cells, Cultured | In Vitro Techniques | Methylene Blue - pharmacology | Photochemotherapy
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 06/2017, Volume 325, pp. 1 - 8
The thionine dye, methylene blue (MB), is a potent inhibitor of monoamine oxidase (MAO) A, a property that may, at least in part, mediate its antidepressant... 
Cresyl violet | MAO | Monoamine oxidase | Inhibition | Nile blue | Methylene blue | VITRO PHOTODYNAMIC INACTIVATION | HIGH-POTENCY | PHOTOBACTERICIDAL ACTIVITY | SEROTONIN TOXICITY | IN-VITRO | CANDIDA-ALBICANS | PHENOTHIAZINE DYES | PHARMACOLOGY & PHARMACY | IFOSFAMIDE ENCEPHALOPATHY | STAPHYLOCOCCUS-AUREUS | TOXICOLOGY | MANIC-DEPRESSIVE PSYCHOSIS | Recombinant Proteins - metabolism | Monoamine Oxidase Inhibitors - pharmacology | Neutral Red - pharmacology | Risk Assessment | Humans | Methylene Blue - toxicity | Serotonin Syndrome - enzymology | Structure-Activity Relationship | Methylene Blue - pharmacology | Dose-Response Relationship, Drug | Methylene Blue - analogs & derivatives | Serotonin Syndrome - chemically induced | Monoamine Oxidase Inhibitors - toxicity | Benzoxazines - pharmacology | Protein Binding | Molecular Docking Simulation | Molecular Structure | Monoamine Oxidase Inhibitors - chemistry | Binding Sites | Methylene Blue - chemistry | Monoamine Oxidase - metabolism | Oxazines - pharmacology | Hallucinogenic drugs | Antidepressants | Analysis | Enzymes | Serotonin | Metabolites | Nitric oxide | Index Medicus | NITRIC OXIDE | TOXICITY | 60 APPLIED LIFE SCIENCES | METHYLENE BLUE | ISOALLOXAZINES | STRUCTURE-ACTIVITY RELATIONSHIPS | ANTIDEPRESSANTS | INHIBITION | OXIDASES | SEROTONIN | PYRAZINES | THIONINE | ADENINES
Journal Article
Metabolic Brain Disease, ISSN 0885-7490, 10/2017, Volume 32, Issue 5, pp. 1357 - 1382
Methylene Blue (MB) is considered to have diverse medical applications and is a well-described treatment for methemoglobinemias and ifosfamide-induced... 
Nitric oxide synthase, mitochondrial function | Depression | Reactive oxygen species | Monoamine oxidase | Methylene blue | MONOAMINE-OXIDASE | mitochondrial function | NITRIC-OXIDE SYNTHASE | CYTOCHROME-OXIDASE | TAU AGGREGATION | BIPOLAR DISORDER | NEUROSCIENCES | SEROTONIN REUPTAKE INHIBITORS | SENSITIVE LINE RAT | MOOD DISORDERS | CYCLIC GUANOSINE-MONOPHOSPHATE | ENDOCRINOLOGY & METABOLISM | Nitric oxide synthase | MAJOR DEPRESSIVE DISORDER | Antidepressive Agents - therapeutic use | Methylene Blue - analogs & derivatives | Monoamine Oxidase Inhibitors - therapeutic use | Monoamine Oxidase Inhibitors - pharmacology | Animals | Humans | Methylene Blue - therapeutic use | Nitric Oxide Synthase - antagonists & inhibitors | Antidepressive Agents - pharmacology | Methylene Blue - pharmacology | Monoamine Oxidase - metabolism | Nervous system diseases | Depression, Mental | Antimalarials | Schizophrenia | Bipolar disorder | Superoxide | Cyclic guanylic acid | Neurophysiology | Antidepressants | Nitric oxide | Analysis | Alzheimer's disease | Neurosciences | Mental disorders | Guanosine | Oxidase | Medical services | Disorders | Clinical trials | Nervous system | Mental depression | Guanylate cyclase | Psychosis | Mitochondria | Encephalopathy | Cyclic GMP | Anxiety | Medical research | Neurodegenerative diseases | Ifosfamide | Therapeutic applications | Pharmacology | Nitric-oxide synthase | Amine oxidase (flavin-containing) | Mood | Inhibitors | Antimalarial agents
Journal Article
Journal Article